1-4 of 4
Ronald K. Blackman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun, Kevin P. Foley, David A. Proia, Ronald K. Blackman, Dan Zhou, Takayo Inoue, Noriaki Tatsuta, Jim Sang, Shuxia Ye, Jamie Acquaviva, Luisa Shin Ogawa, Yumiko Wada, James Barsoum, Keizo Koya
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 475–484.
https://doi.org/10.1158/1535-7163.MCT-11-0755
Published: 08 February 2012
View article titled, Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy
Open the PDF for Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract C11: The oxidative stress inducer elesclomol requires copper chelation for its anticancer activity

Masazumi Nagai, Nha Vho, Elena Kostik, Suqin He, Jane Kepros, Luisa S. Ogawa, Takayo Inoue, Ronald K. Blackman, Yumiko Wada, James Barsoum
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C11.
https://doi.org/10.1158/1535-7163.TARG-09-C11
Published: 10 December 2009
View article titled, Abstract C11: The oxidative stress inducer elesclomol requires copper chelation for its anticancer activity
Journal Articles

Abstract B199: In vitro and in vivo efficacy of the novel Hsp90 inhibitor STA‐9090 and its synergy with paclitaxel

Weiwen Ying, Ronald K. Blackman, Dinesh Chimmanamada, Zhenjian Du, Kevin P. Foley, Suqin He, Takayo Inoue, David James, Jane Kepros, Tim Korbut, Luisa Shin Ogawa, Cong Peng, Teresa Przewloka, David Proia, Jim Sang, Donald Smith, Noriaki Tatsuta, Chin‐Yu Yang, Chaohua Zhang, Haili Zhang, Shijie Zhang, Shaoguang Li, James Barsoum
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B199.
https://doi.org/10.1158/1535-7163.TARG-09-B199
Published: 10 December 2009
View article titled, Abstract B199: <em>In vitro</em> and <em>in vivo</em> efficacy of the novel Hsp90 inhibitor STA‐9090 and its synergy with paclitaxel
Journal Articles

Biological characterization of MLN944: A potent DNA binding agent

Darshan S. Sappal, A. Kathleen McClendon, James A. Fleming, Vala Thoroddsen, Kelly Connolly, Corinne Reimer, Ronald K. Blackman, Christine E. Bulawa, Neil Osheroff, Peter Charlton, Laura A. Rudolph-Owen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (1): 47–58.
https://doi.org/10.1158/1535-7163.47.3.1
Published: 28 January 2004
View article titled, Biological characterization of MLN944: A potent DNA binding agent
Open the PDF for Biological characterization of MLN944: A potent DNA binding agent in another window